Pharmacology, Toxicology and Pharmaceutical Science
Glycogen Synthase Kinase 3
94%
Chronic Obstructive Lung Disease
91%
Fibrosing Alveolitis
85%
Chronic Lung Disease
68%
Disease
61%
Beta Catenin
61%
Fibrinogen
54%
Transforming Growth Factor
54%
Synapsin I
50%
Cigarette Smoke
47%
Guinea Pig Model
47%
Lipopolysaccharide-Induced Lung Inflammation
47%
Mouse
38%
Lung Fibrosis
37%
Lipopolysaccharide
35%
Asthma
35%
Cytokine
32%
Receptor
31%
2 (2,4 Dichlorophenyl) 3 (1 Methyl 3 Indolyl)maleimide
31%
Integrase
29%
Fibronectin
28%
Interleukin 6
27%
Cyclic AMP Dependent Protein Kinase Anchoring Protein
27%
Inflammation
25%
Airway Remodeling
25%
Tumor Necrosis Factor
25%
Pneumonia
24%
Protein Glutamine Gamma Glutamyltransferase 2
23%
Phosphatidylinositol 3 Kinase
23%
Lung Dysplasia
23%
Transforming Growth Factor Beta
23%
Amlexanox
23%
Muscle Atrophy
23%
Cyclic AMP Dependent Protein Kinase
23%
Transforming Growth Factor Beta1
23%
Interleukin 1beta
23%
Frizzled Protein
23%
Bronchoconstriction
23%
Phosphodiesterase IV Inhibitor
23%
Cyclic AMP
23%
Lung Disease
20%
Cell Culture
19%
Methacholine
19%
Cholinergic Receptor Blocking Agent
19%
Small Interfering RNA
19%
Guinea Pig
16%
Protein
15%
Bleomycin-Induced Pulmonary Fibrosis
15%
Nose Polyp
15%
Smooth Muscle Actin
15%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Airway Smooth Muscle
96%
Airway Smooth Muscle Cell
75%
Beta-Catenin
75%
Chronic Lung Disease
68%
Glycogen Synthase Kinase 3
56%
Signal Transduction
55%
Idiopathic Pulmonary Fibrosis
43%
Pulmonary Pathology
35%
Extracellular Matrix
34%
Asthma
33%
Disease
32%
Catenin
29%
Lung Development
27%
Organoid
26%
Lung Dysplasia
23%
Cyclic AMP Dependent Protein Kinase
23%
Glycogen Synthase Kinase 3beta
23%
Cyclic AMP Dependent Protein Kinase Anchoring Protein
23%
Transforming Growth Factor Beta1
23%
Skeletal Muscle Atrophy
23%
Frizzled Protein
23%
Lipopolysaccharide-Induced Lung Inflammation
23%
Lung Physiology
23%
Transforming Growth Factor Beta
23%
Fibroblast
23%
Receptor
23%
Smooth Muscle
23%
Amlexanox
23%
Phosphoinositide 3-Kinase
23%
Pneumonia
19%
Cell Proliferation
19%
Myofibroblast
18%
2 (2,4 Dichlorophenyl) 3 (1 Methyl 3 Indolyl)maleimide
17%
Emphysema
15%
Maturation
15%
Protein
15%
Smooth Muscle Cell
15%
Actin
15%
Growth Factor
14%
Cell Culture
11%
Glycogen Synthase Kinase 3 Inhibitor
11%
mRNA Stability
11%
Muscle Atrophy
11%
Silo-Filler's Disease
11%
Lipopolysaccharide
11%
Tumor Necrosis Factor
11%
Glucocorticoid
11%
Muscle Development
11%
Protein Expression
11%
Keyphrases
Wnt5a
47%
Canonical Wnt Signaling
47%
Wnt Signaling
41%
Wnt Signaling Pathway
38%
Chronic Obstructive Pulmonary Disease
33%
A-kinase Anchoring Protein
25%
Gene Transcription
23%
Lung Repair
23%
Receptor Signaling
23%
Target Deconvolution
23%
WISP1
23%
Pulmonary Fibrosis
23%
PDE4 Inhibitor
23%
Steroid Resistance
23%
Leukotriene B4 (LTB4)
23%
MiR-92a
23%
Signaling Axis
23%
Bronchoconstriction
23%
Lung Physiology
23%
Molecular Mechanism
23%
Transforming Growth Factor-β
23%
Pharmacological Targets
23%
Airway
23%
Lung Slice
23%
Skeletal muscle Atrophy
23%
Transglutaminase 2
23%
Co-receptor
23%
Lung Pathology
23%
Hypercontractivity
23%
Human Airway Smooth muscle
23%
Proliferation Marker
23%
Protein Kinase
23%
Amlexanox
23%
Diesel Exhaust Particles
23%
Mitochondrial Bioenergetics
23%
Human Bronchial Epithelial Cells
23%
Cyclic Adenosine Monophosphate (cAMP)
23%
Methacholine
19%
Tiotropium
15%
Idiopathic Pulmonary Fibrosis
15%
Ht31
15%
Airway Remodeling
13%
Protein Expression
11%
Signaling Pathway
11%
Adult Lung
11%
CYP19A1
11%
Signal Transduction
11%
Nasal Polyps
11%
Glycopyrrolate
11%
Roflumilast
11%
